HOME >> BIOLOGY >> NEWS
Excess iron stores more common than anemia in study of U.S. elderly

Fleming et al.conducted a study of iron nutrition in the elderly, who are the fastest growing segment of the U.S. population. The results, published in the American Journal of Clinical Nutrition, suggest that excess iron stores pose a greater health risk than iron deficiency in the elderly, because elevated iron stores have been linked to chronic diseases such as cancer, diabetes and heart disease.

The 1016 participants were all surviving members of the original cohort of the Framingham Heart study and ranged in age from 67 to 96. In contrast to the relatively low incidence of depleted iron stores in the study population (3%), the prevalence of high iron stores was much greater (12.9%). To determine the effects of chronic disease conditions on the results, the researchers identified a subset of 182 subjects with indications of chronic inflammation, infection, liver disease, hereditary blood disorders or active cancer. This group exhibited a significantly different profile of iron nutrition than the normal group of 834 subjects, with 1.5-fold greater incidence of high iron stores and a 2.6-fold higher prevalence of anemia. Whereas the positive relation between high iron stores and disease remains controversial, the anemia of chronic disease is a well-recognized disorder that accompanies most acute or chronic conditions.

Given the adequacy of iron status in this population of free-living elderly, the use of unprescribed iron supplements could be detrimental.


'"/>

Contact: Elizabeth Horowitz
horowitz@ascn.faseb.org
301-571-5727
American Journal of Clinical Nutrition
21-Feb-2001


Page: 1

Related biology news :

1. Excess thyroid hormone harmful to fetus
2. Excess levels of nitrogen, phosphorus linked to deformed frogs
3. Excessive growth of bacteria may also be major cause of stomach ulcers
4. Excessive fishing prompted coastal ecosystems to collapse, but wise management now will help
5. Choice of sex in animal breeding? Excess of male progeny from males carrying mouse responder transgene on Y chromosome
6. Excess Thiamine May Help Tumor Growth, Research Shows
7. Intake Of Acetaminophen Increases Risk Of Excessive Anticoagulation In Patients Taking Warfarin
8. Scientists visualise cellular handmaiden that restores shape to proteins
9. Scientists find 75 percent of red snapper sold in stores is really some other species
10. UCLA scientists decipher how the brain retrieves and stores our oldest memories
11. A new study sheds light on how the tongue restores its ability to taste following surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Excess iron stores more common than anemia study elderly

(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... Many factors, both genetic and environmental, have been ... of schizophrenia. Some, such as a family history ... infection with Toxoplasma gondii , a parasite ... are still viewed with skepticism. , A new ... and epidemiology at the University of Pennsylvania,s School ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
(Date:10/27/2014)... and TORONTO , Oct. ... www.generex.com ) (OTCQB: GNBT) today announced two presentations ... triggered by its novel proprietary cancer immunotherapeutic AE37 ... breast cancer patients. The AE37 cancer vaccine is ... Express, Inc. ( www.antigenexpress.com ). The presentations are ...
(Date:10/27/2014)... Orlando, Florida (PRWEB) October 27, 2014 ... aims at reducing and eliminating several types of ... have not been achieved in over 30 years ... of Noah's Light Foundation, proves that one mom's ... was diagnosed just before Halloween trick-or-treating, and it’s ...
(Date:10/27/2014)... October 27, 2014 Investor-Edge has ... (NASDAQ: NBIX ), Insmed Inc. (NASDAQ: ... BCRX ), Dyax Corporation (NASDAQ: DYAX ), ... five companies can be accessed at: http://investor-edge.com/register ... Composite ended at 4,483.72, up 0.69%, the Dow Jones ...
(Date:10/25/2014)... 2014 ViaDerma, Inc ... devoted to bringing new products to market, is ... ViaDerma has developed an innovative, patent-pending dual carrier ... transfer of pharmaceutical active ingredients to penetrate the ... localized therapy. The transdermal delivery method also overcomes ...
Breaking Biology Technology:Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
Cached News: